HAL, TER, CCJ, KDP, MRK: Earnings Preview

By Kirsteen Mackay

Published:

In this article

  • Loading...
  • Want to see what you should be buying? Check out our top picks.

This week’s company earnings include Halliburton (NYSE: HAL), Teradyne (NASDAQ: TER), Cameco (CCO) (CCJ), Keurig Dr Pepper (NASDAQ: KDP), and Merck & Co (MRK).

HAL, TER, CCJ, KDP, MRK: Earnings Preview

Meanwhile, S&P heavyweights close out October as Microsoft (NASDAQ: MSFT), Alphabet (NASDAQ: GOOGL), Meta Platforms (NASDAQ: META), Apple (NASDAQ: AAPL), and Amazon (NASDAQ: AMZN) also report their earnings. With Tesla (NASDAQ: TSLA) and Snap (NYSE: SNAP) recently disappointing investors with their quarterly results, all eyes will be on big tech.

Here are five stocks on our radar this week:

Halliburton (NYSE: HAL)

Halliburton Company (NYSE: HAL) reports quarterly earnings on October 25 before the market opens. FactSet analyst estimates provide an EPS consensus of $0.56 and a sales consensus of $5.34bn.

As one of the world's largest providers of products and services to the energy industry, Halliburton is subject to volatility. A stock with a beta higher than 1.0 is expected to be more volatile than the S&P 500. HAL stock has a 52-week beta of 2.13.

Halliburton's market cap is $32.5bn. After enduring a three-month drop from June to September, the HAL share price has since rebounded.

Year-to-date, the Halliburton stock price is up 41.23%, while the S&P 500 is down -21.76% over the same period. And over the past year, HAL stock has traded between $20.77 and $43.99. Today it trades at around $33.88.

FactSet analysts have a consensus Overweight rating on HAL stock with a target share price of $41.69.

HAL stock has a price-to-earnings ratio (P/E) of 21.23 and a price-to-book-value (P/BV) of 4.29. It comes with a dividend yield of 1.4%.

During Q2, Halliburton saw its revenue rise 37% Y/Y. Investors will be keen to see more of the same in Q3.

Teradyne (NASDAQ: TER)

Teradyne, Inc (NASDAQ: TER) will report quarterly earnings on October 25. FactSet analyst estimates provide an EPS consensus of $1.04 and a sales consensus of $800.5m. EPS guidance comes between $0.90 and $1.16, while sales guidance lies between $760m and $840m.

According to Bloomberg, Teradyne, Inc. designs, manufactures, sells, and supports semiconductor test products and services on a worldwide basis. The company's test equipment products and services include semiconductor test systems, military, aerospace test instrumentation, circuit-board test, inspection systems, automotive diagnostic, and test systems. 

Over the past year, TER stock has traded between $67.81 and $168.91. Today it trades at around $77.27. Year-to-date, the Teradyne stock price is down 53.5%.

FactSet analysts have a consensus Overweight rating on TER stock with a target share price of $104.88.

TER stock has a P/E of 16.28. Its P/BV is 5.36. TER stock comes with a dividend yield of 0.6%.

Cameco (NYSE: CCJ) (TSE: CCO)

Uranium company Cameco Corp (NYSE: CCJ) (TSE: CCO) reports quarterly earnings on October 27 before the market open. FactSet analyst estimates provide a sales consensus of $260m.

Cameco recently announced plans to acquire a 49% interest in Westinghouse Electric Company. Read our CCJ stock analysis for more information.

Over the past year, CCJ stock has traded between $18.03 and $32.49. Today it trades at around $23.80. Year-to-date, the Cameco stock price is up 4.8%.

FactSet analysts have a consensus Buy rating on CCJ stock with a target share price of $31.35.

CCJ stock has a P/E of 192 with a forward P/E of 35. Its P/BV is 2.5. CCJ stock comes with a dividend yield of 0.4%.

With the world enduring an energy crisis, interest in uranium stocks is gaining ground.

Keurig Dr Pepper (NASDAQ: KDP)

Keurig Dr Pepper (NASDAQ: KDP) reports quarterly earnings on October 27. FactSet analyst estimates provide an EPS consensus of $0.46 and a sales consensus of $3.63bn.

According to Bloomberg, Keurig Dr Pepper Inc. manufactures and distributes non-alcoholic beverages. The company offers soft drinks, juices, teas, mixers, water, and other beverages. Keurig Dr Pepper serves customers in the United States, Canada, and Mexico.

PepsiCo (NASDAQ: PEP) recently reported upbeat earnings, so investors will be hoping KDP does the same. Particularly as Keurig Dr Pepper's growing coffee business gives is thought to give it an edge over cold beverage sellers.

Over the past year, KDP stock has traded between $33.35 and $41.31. Today it trades at around $37.62. Year-to-date, the Keurig Dr Pepper stock price is up 2.5%, while the S&P 500 is down -21.76% over the same period. 

FactSet analysts have a consensus Overweight rating on KDP stock with a target share price of $41.13. 

KDP stock has a P/E of 24.7 with a forward P/E of 20.7. Its P/BV is 2.1. The KDP dividend yield is 2.1%.

Merck & Co (NYSE: MRK)

Merck & Co (NYSE: MRK) reports quarterly earnings on October 27 before the market opens. FactSet analyst estimates provide an EPS consensus of $1.72 and a sales consensus of $14.07bn.

According to Bloomberg, Merck & Co., Inc. is a global healthcare company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets directly and through its joint ventures. The company has operations in pharmaceutical, animal health, and consumer care. 

Over the past year, MRK stock has traded between $71.50 and $95.96. Today it trades at around $95.67. Year-to-date, the Merck & Co stock price is up 24.5%, while the S&P 500 is down -21.76% over the same period.

FactSet analysts have a consensus Overweight rating on MRK stock with a target share price of $101.85. 

MRK stock has a P/E of 14.59. Its P/BV is 5.60. MRK stock comes with a dividend yield of 2.88%.

Healthcare remains a defensive sector, and MRK is a closely followed stock.

If you enjoyed our earnings preview, why not read our IPO coverage?

Explore more on these topics:

Share:

IMPORTANT NOTICE AND DISCLAIMER

This article does not provide any financial advice and is not a recommendation to deal in any securities or product. Investments may fall in value and an investor may lose some or all of their investment. Past performance is not an indicator of future performance.

Kirsteen Mackay does not hold any position in the stock(s) and/or financial instrument(s) mentioned in the above article.

Kirsteen Mackay has not been paid to produce this piece by the company or companies mentioned above.

Digitonic Ltd, the owner of ValueTheMarkets.com, does not hold a position or positions in the stock(s) and/or financial instrument(s) mentioned in the above article.

Digitonic Ltd, the owner of ValueTheMarkets.com, has not been paid for the production of this piece by the company or companies mentioned above.

Sign up for Investing Intel Newsletter